{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-007673","form_type":"8-K","ticker":"TXG","cik":"0001770787","company_name":"10x Genomics, Inc.","filed_at":"2026-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.123478+00:00","generated_at":"2026-05-16T03:05:22.117460+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"10x Genomics Q4 revenue $166M (+1% YoY); FY26 guidance $600-625M","bullets":["Q4 2025 revenue $166.0M (+1% YoY); FY25 $642.8M (+5%), ex-settlements $598.7M (-2%).","Q4 net loss $16.3M vs $49.0M loss YoY; FY25 net loss $43.5M vs $182.6M loss YoY.","Operating expenses down 18% Q4 and 17% FY; gross margin 68% Q4 and 69% FY.","FY2026 revenue guidance $600-625M (0-4% growth ex-2025 settlements).","Cash and equivalents $523.4M at year-end, up $130M vs prior year."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-007673","json":"https://secwatch.observer/filing/0001628280-26-007673.json","markdown":"https://secwatch.observer/filing/0001628280-26-007673.md","text":"https://secwatch.observer/filing/0001628280-26-007673.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1770787/000162828026007673/0001628280-26-007673-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1770787/000162828026007673/txg-20260212.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T03:05:22.117460+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}